Skip to main content
. 2022 May 10;13:902990. doi: 10.3389/fmicb.2022.902990

Table 2.

Antitumor activity of lanthomicins.

Tumor cell lines IC50 (μM/L)
Doxorubicin Lanthomicin A Lanthomicin B Lanthomicin C
A-549 (lung) 0.02 0.17 >100 >100
MCF-7 (breast) 0.62 5.98 >100 >100
HepG2 (liver) 4.38 34.34 >100 >100
HCT-116 (colon) 10.58 82.27 >100 >100